LECAP Asset Management
HALO icon

LECAP Asset Management’s Halozyme HALO Stock Holding History

LECAP Asset Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-3,740
Closed -$293K – 314
2026
Q2 		$293K Sell
3,740
-3,609
-49% -$246K 0.13% 241
2026
Q1 		$475K Sell
7,349
-1,814
-20% -$128K 0.18% 197
2025
Q4 		$617K Buy
9,163
+1,200
+15% +$80.7K 0.25% 154
2025
Q3 		$584K Buy
+7,963
New +$529K 0.2% 189

Other funds holding HALO

Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Livforsakringsbolaget Skandia
Livforsakringsbolaget Skandia Stockholm, Sweden $3.02B AUM 43.19% 1-Year Est. Return

LECAP Asset Management's HALO Position: Q3 2026 in Review

LECAP Asset Management sold out of Halozyme (HALO) in Q3 2026, closing a stake of 3,740 shares — an estimated $293K sold.

LECAP Asset Management first reported a position in HALO in Q3 2025 and held it in 4 quarters. The position peaked at $617K in Q4 2025. 210 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • LECAP Asset Management reported no remaining Halozyme position as of Q3 2026 after selling out during the quarter.
  • LECAP Asset Management sold 3,740 Halozyme shares in Q3 2026, an estimated $293K.
  • LECAP Asset Management first reported a position in Halozyme in Q3 2025 and held it in 4 quarters.
  • LECAP Asset Management's Halozyme position peaked at $617K in Q4 2025.
  • 210 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on LECAP Asset Management's 13F filing for Q3 2026, filed 27 Oct 2026.